Compile Data Set for Download or QSAR
Report error Found 145 Enz. Inhib. hit(s) with all data for entry = 50039521
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379339(CHEMBL2011940)
Affinity DataIC50: 3nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetAurora kinase B(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379339(CHEMBL2011940)
Affinity DataIC50: 4nMAssay Description:Inhibition of Aurora B kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetInhibitor of nuclear factor kappa-B kinase subunit epsilon(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379339(CHEMBL2011940)
Affinity DataIC50: 4nMAssay Description:Inhibition of Ikkepsilon using 5FAM-AKELDQGSLCTpSFVGTLQ-NH2 as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379339(CHEMBL2011940)
Affinity DataEC50:  4nMAssay Description:Inhibition of TBK1-mediated NFkappaB activation expressed in ds-RNA activated HEK293 cells coexpressing TLR3 after 4.5 hrs by luciferase reporter gen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379357(CHEMBL2011933)
Affinity DataIC50: 4nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379356(CHEMBL2011932)
Affinity DataIC50: 4nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379364(CHEMBL2011942)
Affinity DataIC50: 4nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379363(CHEMBL2011941)
Affinity DataIC50: 4nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379358(CHEMBL2011934)
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetInhibitor of nuclear factor kappa-B kinase subunit epsilon(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379356(CHEMBL2011932)
Affinity DataIC50: 5nMAssay Description:Inhibition of Ikkepsilon using 5FAM-AKELDQGSLCTpSFVGTLQ-NH2 as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379358(CHEMBL2011934)
Affinity DataEC50:  6nMAssay Description:Inhibition of TBK1-mediated NFkappaB activation expressed in ds-RNA activated HEK293 cells coexpressing TLR3 after 4.5 hrs by luciferase reporter gen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379357(CHEMBL2011933)
Affinity DataEC50:  6nMAssay Description:Inhibition of TBK1-mediated NFkappaB activation expressed in ds-RNA activated HEK293 cells coexpressing TLR3 after 4.5 hrs by luciferase reporter gen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379354(CHEMBL2011930)
Affinity DataIC50: 7nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetAurora kinase B(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379358(CHEMBL2011934)
Affinity DataIC50: 7nMAssay Description:Inhibition of Aurora B kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379337(CHEMBL2011936)
Affinity DataEC50:  8nMAssay Description:Inhibition of TBK1-mediated NFkappaB activation expressed in ds-RNA activated HEK293 cells coexpressing TLR3 after 4.5 hrs by luciferase reporter gen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379359(CHEMBL2011935)
Affinity DataIC50: 8nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379365(CHEMBL2011943)
Affinity DataIC50: 9nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetInhibitor of nuclear factor kappa-B kinase subunit epsilon(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379364(CHEMBL2011942)
Affinity DataIC50: 9nMAssay Description:Inhibition of Ikkepsilon using 5FAM-AKELDQGSLCTpSFVGTLQ-NH2 as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379337(CHEMBL2011936)
Affinity DataIC50: 10nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379353(CHEMBL2011929)
Affinity DataIC50: 10nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379354(CHEMBL2011930)
Affinity DataEC50:  11nMAssay Description:Inhibition of TBK1-mediated NFkappaB activation expressed in ds-RNA activated HEK293 cells coexpressing TLR3 after 4.5 hrs by luciferase reporter gen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379363(CHEMBL2011941)
Affinity DataEC50:  12nMAssay Description:Inhibition of TBK1-mediated NFkappaB activation expressed in ds-RNA activated HEK293 cells coexpressing TLR3 after 4.5 hrs by luciferase reporter gen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetAurora kinase B(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379363(CHEMBL2011941)
Affinity DataIC50: 13nMAssay Description:Inhibition of Aurora B kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379353(CHEMBL2011929)
Affinity DataEC50:  14nMAssay Description:Inhibition of TBK1-mediated NFkappaB activation expressed in ds-RNA activated HEK293 cells coexpressing TLR3 after 4.5 hrs by luciferase reporter gen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetAurora kinase B(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379359(CHEMBL2011935)
Affinity DataIC50: 16nMAssay Description:Inhibition of Aurora B kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379367(CHEMBL2011945)
Affinity DataEC50:  17nMAssay Description:Inhibition of TBK1-mediated NFkappaB activation expressed in ds-RNA activated HEK293 cells coexpressing TLR3 after 4.5 hrs by luciferase reporter gen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetInhibitor of nuclear factor kappa-B kinase subunit epsilon(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379363(CHEMBL2011941)
Affinity DataIC50: 17nMAssay Description:Inhibition of Ikkepsilon using 5FAM-AKELDQGSLCTpSFVGTLQ-NH2 as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379355(CHEMBL2011931)
Affinity DataIC50: 18nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetInhibitor of nuclear factor kappa-B kinase subunit epsilon(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379358(CHEMBL2011934)
Affinity DataIC50: 20nMAssay Description:Inhibition of Ikkepsilon using 5FAM-AKELDQGSLCTpSFVGTLQ-NH2 as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379356(CHEMBL2011932)
Affinity DataEC50:  20nMAssay Description:Inhibition of TBK1-mediated NFkappaB activation expressed in ds-RNA activated HEK293 cells coexpressing TLR3 after 4.5 hrs by luciferase reporter gen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetInhibitor of nuclear factor kappa-B kinase subunit epsilon(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379357(CHEMBL2011933)
Affinity DataIC50: 21nMAssay Description:Inhibition of Ikkepsilon using 5FAM-AKELDQGSLCTpSFVGTLQ-NH2 as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetAurora kinase B(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379352(CHEMBL2011928)
Affinity DataIC50: 24nMAssay Description:Inhibition of Aurora B kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetAurora kinase B(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379355(CHEMBL2011931)
Affinity DataIC50: 25nMAssay Description:Inhibition of Aurora B kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379355(CHEMBL2011931)
Affinity DataEC50:  25nMAssay Description:Inhibition of TBK1-mediated NFkappaB activation expressed in ds-RNA activated HEK293 cells coexpressing TLR3 after 4.5 hrs by luciferase reporter gen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379362(CHEMBL2011939)
Affinity DataEC50:  26nMAssay Description:Inhibition of TBK1-mediated NFkappaB activation expressed in ds-RNA activated HEK293 cells coexpressing TLR3 after 4.5 hrs by luciferase reporter gen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetAurora kinase B(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379356(CHEMBL2011932)
Affinity DataIC50: 29nMAssay Description:Inhibition of Aurora B kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetAurora kinase B(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379353(CHEMBL2011929)
Affinity DataIC50: 30nMAssay Description:Inhibition of Aurora B kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetAurora kinase B(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379351(CHEMBL2011927)
Affinity DataIC50: 31nMAssay Description:Inhibition of Aurora B kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379366(CHEMBL2011944)
Affinity DataIC50: 32nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379368(CHEMBL2010815)
Affinity DataEC50:  34nMAssay Description:Inhibition of TBK1-mediated NFkappaB activation expressed in ds-RNA activated HEK293 cells coexpressing TLR3 after 4.5 hrs by luciferase reporter gen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379366(CHEMBL2011944)
Affinity DataEC50:  35nMAssay Description:Inhibition of TBK1-mediated NFkappaB activation expressed in ds-RNA activated HEK293 cells coexpressing TLR3 after 4.5 hrs by luciferase reporter gen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379368(CHEMBL2010815)
Affinity DataIC50: 38nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetAurora kinase B(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379357(CHEMBL2011933)
Affinity DataIC50: 38nMAssay Description:Inhibition of Aurora B kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379351(CHEMBL2011927)
Affinity DataIC50: 39nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379367(CHEMBL2011945)
Affinity DataIC50: 40nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379359(CHEMBL2011935)
Affinity DataEC50:  40nMAssay Description:Inhibition of TBK1-mediated NFkappaB activation expressed in ds-RNA activated HEK293 cells coexpressing TLR3 after 4.5 hrs by luciferase reporter gen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetAurora kinase B(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379350(CHEMBL2011926)
Affinity DataIC50: 43nMAssay Description:Inhibition of Aurora B kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetInhibitor of nuclear factor kappa-B kinase subunit epsilon(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379365(CHEMBL2011943)
Affinity DataIC50: 46nMAssay Description:Inhibition of Ikkepsilon using 5FAM-AKELDQGSLCTpSFVGTLQ-NH2 as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetInhibitor of nuclear factor kappa-B kinase subunit epsilon(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379359(CHEMBL2011935)
Affinity DataIC50: 46nMAssay Description:Inhibition of Ikkepsilon using 5FAM-AKELDQGSLCTpSFVGTLQ-NH2 as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase TBK1(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50379362(CHEMBL2011939)
Affinity DataIC50: 46nMAssay Description:Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
Displayed 1 to 50 (of 145 total ) | Next | Last >>
Jump to: